Bank of New York Mellon
JANX icon

Bank of New York Mellon’s Janux Therapeutics JANX Stock Holding History

Bank of New York Mellon’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Buy
135,072
+15,246
+13% +$221K ﹤0.01% 2925
2026
Q1 		$1.67M Sell
119,826
-2,240
-2% -$30.7K ﹤0.01% 2909
2025
Q4 		$1.68M Buy
122,066
+1,594
+1% +$37.5K ﹤0.01% 2940
2025
Q3 		$2.94M Buy
120,472
+5,773
+5% +$141K ﹤0.01% 2614
2025
Q2 		$2.65M Buy
114,699
+25,329
+28% +$667K ﹤0.01% 2614
2025
Q1 		$2.41M Buy
89,370
+10,511
+13% +$396K ﹤0.01% 2598
2024
Q4 		$4.22M Sell
78,859
-7,976
-9% -$422K ﹤0.01% 2382
2024
Q3 		$3.94M Sell
86,835
-28,192
-25% -$1.23M ﹤0.01% 2411
2024
Q2 		$4.82M Buy
115,027
+66,340
+136% +$3.11M ﹤0.01% 2364
2024
Q1 		$1.83M Sell
48,687
-4,059
-8% -$88.4K ﹤0.01% 2807
2023
Q4 		$566K Sell
52,746
-303
-0.6% -$2.62K ﹤0.01% 3486
2023
Q3 		$535K Hold
53,049
– – ﹤0.01% 3507
2023
Q2 		$630K Sell
53,049
-42
-0.1% -$561 ﹤0.01% 3470
2023
Q1 		$642K Sell
53,091
-414
-0.8% -$6.89K ﹤0.01% 3357
2022
Q4 		$705K Buy
53,505
+3,412
+7% +$49.9K ﹤0.01% 3365
2022
Q3 		$679K Buy
50,093
+7,707
+18% +$103K ﹤0.01% 3398
2022
Q2 		$517K Sell
42,386
-3,615
-8% -$42.8K ﹤0.01% 3560
2022
Q1 		$660K Buy
46,001
+9,464
+26% +$155K ﹤0.01% 3550
2021
Q4 		$721K Buy
36,537
+5,064
+16% +$106K ﹤0.01% 3573
2021
Q3 		$681K Buy
+31,473
New +$906K ﹤0.01% 3627

Other funds holding JANX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Bank of New York Mellon's JANX Position: Q2 2026 in Review

Bank of New York Mellon increased its Janux Therapeutics (JANX) stake by 13% in Q2 2026, buying an estimated $221K and bringing the position to 135,072 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2925.

Bank of New York Mellon first reported a position in JANX in Q3 2021 and has held it in 20 quarters since. The position peaked at $4.82M in Q2 2024. 92 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • Bank of New York Mellon held 135,072 shares of Janux Therapeutics worth $2.07M as of Q2 2026.
  • Bank of New York Mellon bought 15,246 Janux Therapeutics shares in Q2 2026, an estimated $221K.
  • Janux Therapeutics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2925 holding.
  • Bank of New York Mellon first reported a position in Janux Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Bank of New York Mellon's Janux Therapeutics position peaked at $4.82M in Q2 2024.
  • 92 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.